Such statements include, but are not limited to, statements regarding our new strategy for weight loss care treatments involving GLP-1s and plans to provide GLP-1 customers with access to a broad assortment of FDA-approved medications
Lancet 381 , 117124 (2013)
Key takeaways Health insurers face several key considerations and challenges around approval and reimbursement of GLP-1s
all programs are cash-pay FDA status: Compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality before marketing
Participants on the placebo lost an average of 6% of their weight
A study published in the Journal of Clinical Endocrinology found that patients with autoimmune thyroiditis had significantly higher HOMA-IR scores (a measure of insulin resistance) than matched controls, regardless of TSH levels